Zimmer Biomet Holdings, Inc.

NYSE:ZBH

Medical - Devices

Healthcare
$103.32 +1.00%

+$0.87 today

Market cap
$19.55B
Beta
0.47
P/E (TTM)
22.5
EPS (TTM)
$3.90
Dividend yield
1.09%
52W Low $79.12High $108.29

Volume 2.34M

Average 2.28M

ZBH EBITDA Margin

EBITDA as a percentage of revenue.

Zimmer Biomet Holdings, Inc.NYSE: ZBH

EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026

EBITDA Margin holds steady near 27.5%

EBITDA Margin was 27.5% in Q2 FY2026, down 0.2 pp from a year earlier. On a trailing-twelve-month basis it was 27.5%, down 1.6 pp year over year. Over 3 fiscal years it widened by 5.4 pp.

Context

  • EBITDA Margin widened in 1 of the last 3 fiscal years.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 19 analysts of 37.9% for the fiscal year ending Dec 2026, up from 26.9% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
27.5%-3.5 pp QoQ
Last fiscal yearDec 2025
26.9%-2.4 pp YoY
LTMJun 2026
27.5%-1.6 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-0.2 pp+7.4 pp+7.6 pp
1 year-2.4 pp+11.0 pp+13.4 pp
3 years+5.4 pp+7.7 pp+2.3 pp
5 years+7.7 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
26.9%
Year-over-year change
-2.4pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How ZBH compares with its peers on the latest reported figures

  • ZBH's LTM Jun 2026 EBITDA Margin of 27.5% is the 2nd highest of the 10 companies compared; the peer median is 21.7%.
  • Its year-over-year change of -1.6 pp is the 8th highest of 10, against a peer median of +0.0 pp.
  • Over three fiscal years its change of +5.4 pp compares with a peer median of -0.4 pp.
ZBH Competitors Peer median
EBITDA Margin for ZBH and competitors
Company Period LTM level YoY 3-year change
BSXBoston Scientific CorporationLTM Jun 202627.6% +2.2 pp+3.8 pp
ZBHZimmer Biomet Holdings, Inc.LTM Jun 202627.5% -1.6 pp+5.4 pp
MDTMedtronic plcLTM Jul 202627.3% +0.0 pp-0.9 pp
SYKStryker CorporationLTM Jun 202625.9% +5.9 pp+3.4 pp
EWEdwards Lifesciences CorporationLTM Jun 202624.3% -7.1 pp-12.4 pp
SNNSmith & Nephew plcFY202521.7% -1.3 pp-0.4 pp
ALGNAlign Technology, Inc.LTM Jun 202619.0% -1.3 pp-0.5 pp
PHGKoninklijke Philips N.V.LTM Jun 202617.3% +6.7 pp+14.2 pp
GEHCGE HealthCare Technologies Inc.LTM Jun 202615.2% -4.0 pp+1.1 pp
OFIXOrthofix Medical Inc.LTM Mar 202611.5% +13.4 pp-6.1 pp
Peer median (excluding ZBH) 21.7%+0.0 pp-0.4 pp

Competitors are the stored peer set for ZBH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue6.83B6.94B7.39B7.68B8.23B
Cost of Revenue1.96B2.02B2.08B2.19B3.16B
Gross Profit4.87B4.92B5.31B5.49B5.07B
Gross Margin71.3%70.9%71.8%71.5%61.6%
Research & Development435.8M406M458.7M437.4M458.5M
Selling, General & Admin2.84B2.76B2.84B2.93B3.25B
Operating Expenses4.01B4.22B4.03B4.2B3.71B
Depreciation & Amortization937.7M926.4M951.7M996.3M1.09B
EBITDA1.65B1.49B2.22B2.25B2.22B
EBITDA Margin24.1%21.5%30.0%29.3%26.9%
Operating Income860.3M696.3M1.28B1.29B1.36B
Operating Margin12.6%10.0%17.3%16.7%16.5%
Interest Income00000
Interest Expense208.4M164.8M201.2M218M292.8M
Other Income / Expenses(361.3M)(292.8M)(210.4M)(249.1M)(531.4M)
Income Before Tax499M403.5M1.07B1.04B830.8M
Pre-Tax Margin7.3%5.8%14.4%13.5%10.1%
Income Tax Expense53.5M112.3M42.2M131.4M125.7M
Net Income401.6M231.4M1.02B903.8M705.2M
Net Margin5.9%3.3%13.8%11.8%8.6%
EPS (Basic)1.871.104.914.453.56
EPS (Diluted)1.851.104.884.433.55
Weighted Avg Shares214.86M209.6M208.7M203.1M198M
Weighted Avg Shares (Diluted)216.71M210.3M209.7M203.9M198.7M

Zimmer Biomet Holdings, Inc.

NYSE:ZBH

Intrinsic Alpha fair value

Locked

Current Price

$103.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.